Markus Klein,Rolf Gericke,Norbert Beier,Florian Lang
申请号：
US12374100
公开号：
US08207210B2
申请日:
2007.06.18
申请国别(地区):
US
年份:
2012
代理人:
摘要：
Novel aminoindazolylurea derivatives of the formula I (I), in which R1, R2, R3, R4, R5, X and Y have the meanings indicated in Claim 1, are SGK inhibitors and can be used for the treatment of SGK-induced diseases and complaints, such as diabetes, obesity, metabolic syndrome (dyslipidaemia), systemic and pulmonary hypertonia, cardiovascular diseases and kidney diseases, generally in fibroses and inflammatory processes of any type.
